Industry Research Reports

Home > Reports > Chemical & Material > Milbemycin Oxime API - Global Market Insights and Sales Trends 2024

Milbemycin Oxime API - Global Market Insights and Sales Trends 2024

Industry: Chemical & Material

Published: 2023-11-03

Pages: 75 Pages

Report ld: 1768684

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.

The global Milbemycin Oxime API market size is expected to reach US$ 304 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Milbemycin Oxime API in various end use industries. The expanding demands from the Dog, Cat and Other,, are propelling Milbemycin Oxime API market. 98% Purity, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Purity Greater than 98% segment is estimated at % CAGR for the next seven-year period.

Global 3 largest manufacturers of Milbemycin Oxime API are Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd and Hubei Honch Pharmaceutical Co.,Ltd, which make up over 40%. Among them, Livzon Pharmaceutical Group Inc is the leader with about 22% market share. North America is the largest market, with a share about 48%, followed by Europe and China, with the share about 46% and 2%. In terms of product type, Purity Greater than 98% occupy the largest share of the total market, about 85%. And in terms of product Application, the largest application is Dog, followed by Cat.

Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Milbemycin Oxime API, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:
This report provides in-depth analysis of the global Milbemycin Oxime API market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Milbemycin Oxime API market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Milbemycin Oxime API sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Milbemycin Oxime API covered in this report include Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd, Hubei Honch Pharmaceutical Co.,Ltd and JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD, etc.

The global Milbemycin Oxime API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Report Metric
Details
Report Title
Milbemycin Oxime API - Global Market Insights and Sales Trends 2024
Global Milbemycin Oxime API Companies Covered
Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd, Hubei Honch Pharmaceutical Co.,Ltd, JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
Global Milbemycin Oxime API Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Milbemycin Oxime API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Milbemycin Oxime API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Table of Contents

 1 Milbemycin Oxime API Market Overview
    1.1 Milbemycin Oxime API Product Overview
    1.2 Milbemycin Oxime API Market Segment by Type
        1.2.1 98% Purity
        1.2.2 Purity Greater than 98%
    1.3 Global Milbemycin Oxime API Market Size by Type
        1.3.1 Global Milbemycin Oxime API Market Size Overview by Type (2018-2029)
        1.3.2 Global Milbemycin Oxime API Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Milbemycin Oxime API Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Milbemycin Oxime API Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Milbemycin Oxime API Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Milbemycin Oxime API Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Milbemycin Oxime API Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Milbemycin Oxime API Sales Breakdown by Type (2018-2023)

 2 Global Milbemycin Oxime API Market Competition by Company
    2.1 Global Top Players by Milbemycin Oxime API Sales (2018-2023)
    2.2 Global Top Players by Milbemycin Oxime API Revenue (2018-2023)
    2.3 Global Top Players by Milbemycin Oxime API Price (2018-2023)
    2.4 Global Top Manufacturers Milbemycin Oxime API Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Milbemycin Oxime API Market Competitive Situation and Trends
        2.5.1 Milbemycin Oxime API Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Milbemycin Oxime API Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Milbemycin Oxime API as of 2022)
    2.7 Date of Key Manufacturers Enter into Milbemycin Oxime API Market
    2.8 Key Manufacturers Milbemycin Oxime API Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 Milbemycin Oxime API Status and Outlook by Region
    3.1 Global Milbemycin Oxime API Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Milbemycin Oxime API Historic Market Size by Region
        3.2.1 Global Milbemycin Oxime API Sales in Volume by Region (2018-2023)
        3.2.2 Global Milbemycin Oxime API Sales in Value by Region (2018-2023)
        3.2.3 Global Milbemycin Oxime API Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Milbemycin Oxime API Forecasted Market Size by Region
        3.3.1 Global Milbemycin Oxime API Sales in Volume by Region (2024-2029)
        3.3.2 Global Milbemycin Oxime API Sales in Value by Region (2024-2029)
        3.3.3 Global Milbemycin Oxime API Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global Milbemycin Oxime API by Application
    4.1 Milbemycin Oxime API Market Segment by Application
        4.1.1 Dog
        4.1.2 Cat
        4.1.3 Other
    4.2 Global Milbemycin Oxime API Market Size by Application
        4.2.1 Global Milbemycin Oxime API Market Size Overview by Application (2018-2029)
        4.2.2 Global Milbemycin Oxime API Historic Market Size Review by Application (2018-2023)
        4.2.3 Global Milbemycin Oxime API Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Milbemycin Oxime API Sales Breakdown by Application (2018-2023)
        4.3.2 Europe Milbemycin Oxime API Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific Milbemycin Oxime API Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America Milbemycin Oxime API Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa Milbemycin Oxime API Sales Breakdown by Application (2018-2023)

 5 North America Milbemycin Oxime API by Country
    5.1 North America Milbemycin Oxime API Historic Market Size by Country
        5.1.1 North America Milbemycin Oxime API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Milbemycin Oxime API Sales in Volume by Country (2018-2023)
        5.1.3 North America Milbemycin Oxime API Sales in Value by Country (2018-2023)
    5.2 North America Milbemycin Oxime API Forecasted Market Size by Country
        5.2.1 North America Milbemycin Oxime API Sales in Volume by Country (2024-2029)
        5.2.2 North America Milbemycin Oxime API Sales in Value by Country (2024-2029)

 6 Europe Milbemycin Oxime API by Country
    6.1 Europe Milbemycin Oxime API Historic Market Size by Country
        6.1.1 Europe Milbemycin Oxime API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Milbemycin Oxime API Sales in Volume by Country (2018-2023)
        6.1.3 Europe Milbemycin Oxime API Sales in Value by Country (2018-2023)
    6.2 Europe Milbemycin Oxime API Forecasted Market Size by Country
        6.2.1 Europe Milbemycin Oxime API Sales in Volume by Country (2024-2029)
        6.2.2 Europe Milbemycin Oxime API Sales in Value by Country (2024-2029)

 7 Asia-Pacific Milbemycin Oxime API by Region
    7.1 Asia-Pacific Milbemycin Oxime API Historic Market Size by Region
        7.1.1 Asia-Pacific Milbemycin Oxime API Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Milbemycin Oxime API Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Milbemycin Oxime API Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Milbemycin Oxime API Forecasted Market Size by Region
        7.2.1 Asia-Pacific Milbemycin Oxime API Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Milbemycin Oxime API Sales in Value by Region (2024-2029)

 8 Latin America Milbemycin Oxime API by Country
    8.1 Latin America Milbemycin Oxime API Historic Market Size by Country
        8.1.1 Latin America Milbemycin Oxime API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Milbemycin Oxime API Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Milbemycin Oxime API Sales in Value by Country (2018-2023)
    8.2 Latin America Milbemycin Oxime API Forecasted Market Size by Country
        8.2.1 Latin America Milbemycin Oxime API Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Milbemycin Oxime API Sales in Value by Country (2024-2029)

 9 Middle East and Africa Milbemycin Oxime API by Country
    9.1 Middle East and Africa Milbemycin Oxime API Historic Market Size by Country
        9.1.1 Middle East and Africa Milbemycin Oxime API Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Milbemycin Oxime API Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Milbemycin Oxime API Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Milbemycin Oxime API Forecasted Market Size by Country
        9.2.1 Middle East and Africa Milbemycin Oxime API Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Milbemycin Oxime API Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 Livzon Pharmaceutical Group Inc
        10.1.1 Livzon Pharmaceutical Group Inc Company Information
        10.1.2 Livzon Pharmaceutical Group Inc Introduction and Business Overview
        10.1.3 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Products Offered
        10.1.5 Livzon Pharmaceutical Group Inc Recent Development
    10.2 Zhejiang Hisun Pharmaceutical Co., Ltd
        10.2.1 Zhejiang Hisun Pharmaceutical Co., Ltd Company Information
        10.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd Introduction and Business Overview
        10.2.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Products Offered
        10.2.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Development
    10.3 Hubei Honch Pharmaceutical Co.,Ltd
        10.3.1 Hubei Honch Pharmaceutical Co.,Ltd Company Information
        10.3.2 Hubei Honch Pharmaceutical Co.,Ltd Introduction and Business Overview
        10.3.3 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Products Offered
        10.3.5 Hubei Honch Pharmaceutical Co.,Ltd Recent Development
    10.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD
        10.4.1 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Company Information
        10.4.2 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Introduction and Business Overview
        10.4.3 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Products Offered
        10.4.5 JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Milbemycin Oxime API Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Milbemycin Oxime API Industrial Chain Analysis
    11.4 Milbemycin Oxime API Market Dynamics
        11.4.1 Milbemycin Oxime API Industry Trends
        11.4.2 Milbemycin Oxime API Market Drivers
        11.4.3 Milbemycin Oxime API Market Challenges
        11.4.4 Milbemycin Oxime API Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Milbemycin Oxime API Distributors
    12.3 Milbemycin Oxime API Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details

Table of Figures

List of Tables
    Table 1. Major Company of 98% Purity
    Table 2. Major Company of Purity Greater than 98%
    Table 3. Global Milbemycin Oxime API Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 4. Global Milbemycin Oxime API Sales by Type (2018-2023) & (KG)
    Table 5. Global Milbemycin Oxime API Sales Market Share in Volume by Type (2018-2023)
    Table 6. Global Milbemycin Oxime API Sales by Type (2018-2023) & (US& Million)
    Table 7. Global Milbemycin Oxime API Market Share in Value by Type (2018-2023)
    Table 8. Global Milbemycin Oxime API Price by Type (2018-2023) & (US$/KG)
    Table 9. Global Milbemycin Oxime API Sales by Type (2024-2029) & (KG)
    Table 10. Global Milbemycin Oxime API Sales Market Share in Volume by Type (2024-2029)
    Table 11. Global Milbemycin Oxime API Sales by Type (2024-2029) & (US$ Million)
    Table 12. Global Milbemycin Oxime API Sales Market Share in Value by Type (2024-2029)
    Table 13. Global Milbemycin Oxime API Price by Type (2024-2029) & (US$/KG)
    Table 14. North America Milbemycin Oxime API Sales by Type (2018-2023) & (KG)
    Table 15. North America Milbemycin Oxime API Sales by Type (2018-2023) & (US$ Million)
    Table 16. Europe Milbemycin Oxime API Sales (KG) by Type (2018-2023)
    Table 17. Europe Milbemycin Oxime API Sales by Type (2018-2023) & (US$ Million)
    Table 18. Asia-Pacific Milbemycin Oxime API Sales (KG) by Type (2018-2023)
    Table 19. Asia-Pacific Milbemycin Oxime API Sales by Type (2018-2023) & (US$ Million)
    Table 20. Latin America Milbemycin Oxime API Sales (KG) by Type (2018-2023)
    Table 21. Latin America Milbemycin Oxime API Sales by Type (2018-2023) & (US$ Million)
    Table 22. Middle East and Africa Milbemycin Oxime API Sales (KG) by Type (2018-2023)
    Table 23. Middle East and Africa Milbemycin Oxime API Sales by Type (2018-2023) & (US$ Million)
    Table 24. Global Milbemycin Oxime API Sales by Company (2018-2023) & (KG)
    Table 25. Global Milbemycin Oxime API Sales Share by Company (2018-2023)
    Table 26. Global Milbemycin Oxime API Revenue by Company (2018-2023) & (US$ Million)
    Table 27. Global Milbemycin Oxime API Revenue Share by Company (2018-2023)
    Table 28. Global Market Milbemycin Oxime API Price by Company (2018-2023) & (US$/KG)
    Table 29. Global Milbemycin Oxime API Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 30. Global Milbemycin Oxime API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Milbemycin Oxime API as of 2022)
    Table 32. Date of Key Manufacturers Enter into Milbemycin Oxime API Market
    Table 33. Key Manufacturers Milbemycin Oxime API Product Type
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Milbemycin Oxime API Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Global Milbemycin Oxime API Sales by Region (2018-2023) & (KG)
    Table 37. Global Milbemycin Oxime API Sales Market Share in Volume by Region (2018-2023)
    Table 38. Global Milbemycin Oxime API Sales by Region (2018-2023) & (US$ Million)
    Table 39. Global Milbemycin Oxime API Sales Market Share in Value by Region (2018-2023)
    Table 40. Global Milbemycin Oxime API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2018-2023)
    Table 41. Global Milbemycin Oxime API Sales by Region (2024-2029) & (KG)
    Table 42. Global Milbemycin Oxime API Sales Market Share in Volume by Region (2024-2029)
    Table 43. Global Milbemycin Oxime API Sales by Region (2024-2029) & (US$ Million)
    Table 44. Global Milbemycin Oxime API Sales Market Share in Value by Region (2024-2029)
    Table 45. Global Milbemycin Oxime API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2024-2029)
    Table 46. Global Milbemycin Oxime API Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 47. Global Milbemycin Oxime API Sales by Application (2018-2023) & (KG)
    Table 48. Global Milbemycin Oxime API Sales Market Share in Volume by Application (2018-2023)
    Table 49. Global Milbemycin Oxime API Sales by Application (2018-2023) & (US$ Million)
    Table 50. Global Milbemycin Oxime API Sales Market Share in Value by Application (2018-2023)
    Table 51. Global Milbemycin Oxime API Price by Application (2018-2023) & (US$/KG)
    Table 52. Global Milbemycin Oxime API Sales by Application (2024-2029) & (KG)
    Table 53. Global Milbemycin Oxime API Sales Market Share in Volume by Application (2024-2029)
    Table 54. Global Milbemycin Oxime API Sales by Application (2024-2029) & (US$ Million)
    Table 55. Global Milbemycin Oxime API Sales Market Share in Value by Application (2024-2029)
    Table 56. Global Milbemycin Oxime API Price by Application (2024-2029) & (US$/KG)
    Table 57. North America Milbemycin Oxime API Sales by Application (2018-2023) (KG) 
    Table 58. North America Milbemycin Oxime API Sales by Application (2018-2023) & (US$ Million)
    Table 59. Europe Milbemycin Oxime API Sales by Application (2018-2023) (KG) 
    Table 60. Europe Milbemycin Oxime API Sales by Application (2018-2023) & (US$ Million)
    Table 61. Asia-Pacific Milbemycin Oxime API Sales by Application (2018-2023) (KG) 
    Table 62. Asia-Pacific Milbemycin Oxime API Sales by Application (2018-2023) & (US$ Million)
    Table 63. Latin America Milbemycin Oxime API Sales by Application (2018-2023) (KG) 
    Table 64. Latin America Milbemycin Oxime API Sales by Application (2018-2023) & (US$ Million)
    Table 65. Middle East and Africa Milbemycin Oxime API Sales by Application (2018-2023) (KG) 
    Table 66. Middle East and Africa Milbemycin Oxime API Sales by Application (2018-2023) & (US$ Million)
    Table 67. North America Milbemycin Oxime API Sales by Country (2018-2023) & (KG)
    Table 68. North America Milbemycin Oxime API Sales Market Share in Volume by Country (2018-2023)
    Table 69. North America Milbemycin Oxime API Sales by Country (2018-2023) & (US$ Million)
    Table 70. North America Milbemycin Oxime API Sales Market Share in Value by Country (2018-2023)
    Table 71. North America Milbemycin Oxime API Sales by Country (2024-2029) & (KG)
    Table 72. North America Milbemycin Oxime API Sales Market Share in Volume by Country (2024-2029)
    Table 73. North America Milbemycin Oxime API Sales by Country (2024-2029) & (US$ Million)
    Table 74. North America Milbemycin Oxime API Sales Market Share in Value by Country (2024-2029)
    Table 75. Europe Milbemycin Oxime API Sales by Country (2018-2023) & (KG)
    Table 76. Europe Milbemycin Oxime API Sales Market Share in Volume by Country (2018-2023)
    Table 77. Europe Milbemycin Oxime API Sales by Country (2018-2023) & (US$ Million)
    Table 78. Europe Milbemycin Oxime API Sales Market Share in Value by Country (2018-2023)
    Table 79. Europe Milbemycin Oxime API Sales by Country (2024-2029) & (KG)
    Table 80. Europe Milbemycin Oxime API Sales Market Share in Volume by Country (2024-2029)
    Table 81. Europe Milbemycin Oxime API Sales by Country (2024-2029) & (US$ Million)
    Table 82. Europe Milbemycin Oxime API Sales Market Share in Value by Country (2024-2029)
    Table 83. Asia-Pacific Milbemycin Oxime API Sales by Region (2018-2023) & (KG)
    Table 84. Asia-Pacific Milbemycin Oxime API Sales Market Share in Volume by Region (2018-2023)
    Table 85. Asia-Pacific Milbemycin Oxime API Sales by Region (2018-2023) & (US$ Million)
    Table 86. Asia-Pacific Milbemycin Oxime API Sales Market Share in Value by Region (2018-2023)
    Table 87. Asia-Pacific Milbemycin Oxime API Sales by Region (2024-2029) & (KG)
    Table 88. Asia-Pacific Milbemycin Oxime API Sales Market Share in Volume by Region (2024-2029)
    Table 89. Asia-Pacific Milbemycin Oxime API Sales by Region (2024-2029) & (US$ Million)
    Table 90. Asia-Pacific Milbemycin Oxime API Sales Market Share in Value by Region (2024-2029)
    Table 91. Latin America Milbemycin Oxime API Sales by Country (2018-2023) & (KG)
    Table 92. Latin America Milbemycin Oxime API Sales Market Share in Volume by Country (2018-2023)
    Table 93. Latin America Milbemycin Oxime API Sales by Country (2018-2023) & (US$ Million)
    Table 94. Latin America Milbemycin Oxime API Sales Market Share in Value by Country (2018-2023)
    Table 95. Latin America Milbemycin Oxime API Sales by Country (2024-2029) & (KG)
    Table 96. Latin America Milbemycin Oxime API Sales Market Share in Volume by Country (2024-2029)
    Table 97. Latin America Milbemycin Oxime API Sales by Country (2024-2029) & (US$ Million)
    Table 98. Latin America Milbemycin Oxime API Sales Market Share in Value by Country (2024-2029)
    Table 99. Middle East and Africa Milbemycin Oxime API Sales by Country (2018-2023) & (KG)
    Table 100. Middle East and Africa Milbemycin Oxime API Sales Market Share in Volume by Country (2018-2023)
    Table 101. Middle East and Africa Milbemycin Oxime API Sales by Country (2018-2023) & (US$ Million)
    Table 102. Middle East and Africa Milbemycin Oxime API Sales Market Share in Value by Country (2018-2023)
    Table 103. Middle East and Africa Milbemycin Oxime API Sales by Country (2024-2029) & (KG)
    Table 104. Middle East and Africa Milbemycin Oxime API Sales Market Share in Volume by Country (2024-2029)
    Table 105. Middle East and Africa Milbemycin Oxime API Sales by Country (2024-2029) & (US$ Million)
    Table 106. Middle East and Africa Milbemycin Oxime API Sales Market Share in Value by Country (2024-2029)
    Table 107. Livzon Pharmaceutical Group Inc Company Information
    Table 108. Livzon Pharmaceutical Group Inc Introduction and Business Overview
    Table 109. Livzon Pharmaceutical Group Inc Milbemycin Oxime API Sales (KG), Revenue (Million USD), Price (US$/KG) and Gross Margin (2018-2023)
    Table 110. Livzon Pharmaceutical Group Inc Milbemycin Oxime API Product
    Table 111. Livzon Pharmaceutical Group Inc Recent Development
    Table 112. Zhejiang Hisun Pharmaceutical Co., Ltd Company Information
    Table 113. Zhejiang Hisun Pharmaceutical Co., Ltd Introduction and Business Overview
    Table 114. Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Sales (KG), Revenue (Million USD), Price (US$/KG) and Gross Margin (2018-2023)
    Table 115. Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Product
    Table 116. Zhejiang Hisun Pharmaceutical Co., Ltd Recent Development
    Table 117. Hubei Honch Pharmaceutical Co.,Ltd Company Information
    Table 118. Hubei Honch Pharmaceutical Co.,Ltd Introduction and Business Overview
    Table 119. Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Sales (KG), Revenue (Million USD), Price (US$/KG) and Gross Margin (2018-2023)
    Table 120. Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Product
    Table 121. Hubei Honch Pharmaceutical Co.,Ltd Recent Development
    Table 122. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Company Information
    Table 123. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Introduction and Business Overview
    Table 124. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Sales (KG), Revenue (Million USD), Price (US$/KG) and Gross Margin (2018-2023)
    Table 125. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Milbemycin Oxime API Product
    Table 126. JIANGSU LINGYUN PHARMACEUTICAL CO.，LTD Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Milbemycin Oxime API Market Trends
    Table 130. Milbemycin Oxime API Market Drivers
    Table 131. Milbemycin Oxime API Market Challenges
    Table 132. Milbemycin Oxime API Market Restraints
    Table 133. Milbemycin Oxime API Distributors List
    Table 134. Milbemycin Oxime API Downstream Customers
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Milbemycin Oxime API Product Picture
    Figure 2. Global Milbemycin Oxime API Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Milbemycin Oxime API Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Milbemycin Oxime API Sales Status and Outlook (2018-2029) & (KG)
    Figure 5. Product Picture of 98% Purity
    Figure 6. Global 98% Purity Sales YoY Growth (2018-2029) & (KG)
    Figure 7. Product Picture of Purity Greater than 98%
    Figure 8. Global Purity Greater than 98% Sales YoY Growth (2018-2029) & (KG)
    Figure 9. Global Milbemycin Oxime API Sales by Type (2018-2029) & (US$ Million)
    Figure 10. Global Milbemycin Oxime API Sales Market Share by Type in 2022 & 2029
    Figure 11. North America Milbemycin Oxime API Sales Market Share in Volume by Type in 2022
    Figure 12. North America Milbemycin Oxime API Sales Market Share in Value by Type in 2022
    Figure 13. Europe Milbemycin Oxime API Sales Market Share in Volume by Type in 2022
    Figure 14. Europe Milbemycin Oxime API Sales Market Share in Value by Type in 2022
    Figure 15. Asia-Pacific Milbemycin Oxime API Sales Market Share in Volume by Type in 2022
    Figure 16. Asia-Pacific Milbemycin Oxime API Sales Market Share in Value by Type in 2022
    Figure 17. Latin America Milbemycin Oxime API Sales Market Share in Volume by Type in 2022
    Figure 18. Latin America Milbemycin Oxime API Sales Market Share in Value by Type in 2022
    Figure 19. Middle East and Africa Milbemycin Oxime API Sales Market Share in Volume by Type in 2022
    Figure 20. Middle East and Africa Milbemycin Oxime API Sales Market Share in Value by Type in 2022
    Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Milbemycin Oxime API Sales in 2022
    Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Milbemycin Oxime API Revenue in 2022
    Figure 23. Milbemycin Oxime API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 24. Product Picture of Dog
    Figure 25. Global Dog Sales YoY Growth (2018-2029) & (KG)
    Figure 26. Product Picture of Cat
    Figure 27. Global Cat Sales YoY Growth (2018-2029) & (KG)
    Figure 28. Product Picture of Other
    Figure 29. Global Other Sales YoY Growth (2018-2029) & (KG)
    Figure 30. Global Milbemycin Oxime API Sales by Application (2018-2029) & (US$ Million)
    Figure 31. Global Milbemycin Oxime API Sales Market Share by Application in 2022 & 2029
    Figure 32. North America Milbemycin Oxime API Sales Market Share in Volume by Application in 2022
    Figure 33. North America Milbemycin Oxime API Sales Market Share in Value by Application in 2022
    Figure 34. Europe Milbemycin Oxime API Sales Market Share in Volume by Application in 2022
    Figure 35. Europe Milbemycin Oxime API Sales Market Share in Value by Application in 2022
    Figure 36. Asia-Pacific Milbemycin Oxime API Sales Market Share in Volume by Application in 2022
    Figure 37. Asia-Pacific Milbemycin Oxime API Sales Market Share in Value by Application in 2022
    Figure 38. Latin America Milbemycin Oxime API Sales Market Share in Volume by Application in 2022
    Figure 39. Latin America Milbemycin Oxime API Sales Market Share in Value by Application in 2022
    Figure 40. Middle East and Africa Milbemycin Oxime API Sales Market Share in Value by Application in 2022
    Figure 41. Key Raw Materials Price
    Figure 42. Milbemycin Oxime API Manufacturing Cost Structure
    Figure 43. Milbemycin Oxime API Industrial Chain Analysis
    Figure 44. Channels of Distribution
    Figure 45. Distributors Profiles
    Figure 46. Bottom-up and Top-down Approaches for This Report
    Figure 47. Data Triangulation
    Figure 48. Key Executives Interviewed

Description

Milbemycin is a new type of semi-synthetic macrolide anthelmintic. It is an oxime derivative of Milbemycin A3 and A4. The molecular weight of A3 oxime is 541.7, and the molecular weight of A4 oxime is 555.7. In terms of application, milbexime can be used alone or in combination with nitenpyram, lufenuron, spinosad, praziquantel, etc. to form a compound preparation, which can effectively prevent and control heartworms, hookworms, roundworms, whipworms, roundworms and other internal parasites, as well as hair follicles, scabies, lice, fleas and other external parasites. Milbexime acts as an agonist of the GABA (gamma-aminobutyric acid) neurotransmitter in nerve cells and also binds to glutamate-gated Cl– channels in invertebrate nerve and muscle cells. In both cases, it blocks the parasite's nerve signaling, eventually paralyzing the parasite, causing the muscles to lose their ability to contract, stop feeding, and cause the parasite to die.

The global Milbemycin Oxime API market size is expected to reach US$ 304 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Milbemycin Oxime API in various end use industries. The expanding demands from the Dog, Cat and Other,, are propelling Milbemycin Oxime API market. 98% Purity, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Purity Greater than 98% segment is estimated at % CAGR for the next seven-year period.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Market Segmentation

Industry: Chemical & Material

Published: 2023-11-03

Pages: 75 Pages

Report ld: 1768684

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License